SABM2022

News & Events

Find the latest news and updates from HemoSonics.

January 19, 2021

HemoSonics Welcomes FDA Support of Viscoelastic Coagulation Analyzers for COVID-19 Patients; Highlights the Benefits of the Quantra® Hemostasis Analyzer

Charlottesville, VA, January 19, 2021 – HemoSonics welcomes the January 14th guidance of the US Food and Drug Administration (FDA) that broadens the use of viscoelastic coagulation analyzers for hospital patient healthcare settings in response to COVID-19. The FDA guidance is intended, for the duration of the COVID-19 public health emergency, to expand the availability […]

Read More

Tags: ,

September 10, 2020

HemoSonics Adds Remote Viewer to its Quantra® QPlus® System, Bringing Rapid Results to Clinicians Anywhere in the Hospital

Charlottesville, VA – September 10, 2020 – HemoSonics announced today that its Quantra Desktop Remote Viewer Software (QDRV) has received a 510(k) clearance from the FDA. The QDRV enables remote access to its flagship product, the Quantra QPlus System. The Quantra System provides rapid, actionable coagulation results at the point of care – now viewable […]

Read More

June 9, 2020

Quality Assurance in Viscoelastic Testing – Reducing the QC Burden with the Quantra® System

In a recent publication entitled Unique Approach to Quality Assurance in Viscoelastic Testing (Leadbetter NH, et al, J Appl Lab Med. 2020 May 20, HemoSonics authors describe a novel POC device, the Quantra QPlus® System, with emphasis on a comprehensive, easy-to-implement QA program. Importantly, the Quantra system’s innovative ultrasound technology enables automatic, frequent QC checks not currently available with other VET devices, that reduce the burden of manual testing and maintenance.

Read More

April 13, 2020

COVID-19 Update from HemoSonics

HemoSonics has responded to requests from several clinical sites in Europe and is supporting their investigations to understand the potential utility of the Quantra System for the evaluation of blood coagulation status in COVID-19 patients at the point-of-care. The Quantra Hemostasis Analyzer and its closed system cartridges (QPlus® and QStat® Cartridges) require no blood manipulation after collection which minimizes potential biological exposure to healthcare professionals.

Read More

Tags:

September 10, 2019

HemoSonics Registers CE Mark for its New QStat® Cartridge, Expanding the Use of its Innovative Quantra® Hemostasis System to Trauma Surgery and Liver Transplant Settings

Charlottesville, VA – September 10, 2019 – HemoSonics is excited to announce that its new QStat Cartridge, an extension of its groundbreaking Quantra Hemostasis System, has registered for CE Mark and is now commercially available in Europe and Hong Kong. The utility of the Quantra System, which was previously available with the QPlus® Cartridge for […]

Read More

Tags: , , ,

Where We Will Be Next:

 
Copy link
CopyCopied
Powered by Social Snap